Search
Close this search box.
/
/
/
“The collection of data for medical cases must be consensual, informed and free”
“The collection of data for medical cases must be consensual, informed and free”

Share the news:

PONS IP, a leading national intellectual and property consultancy, has participated in the neurocomputing event organised by the Working Group of the Artificial Intelligence and Big Data Commission of AMETIC and held at the PONS Foundation under the title ‘The power of connecting the brain to the machine’.

During the meeting, different laboratories were held with live demonstrations of everything that emerging technologies such as Virtual Reality, Spiking Networks, Quantum Sensors and ChatGPT are able to do. In this sense, use cases are divided into clinical, emotional and industrial contexts.

The day also featured various round table discussions to challenge what was demonstrated in these laboratories. On behalf of PONS IP, Of Counsel, expert in data protection and intellectual property, José Carlos Erdozain, was invited to participate in the round table “Discovering neurocomputing. The potential of neurocomputing.” He was joined by Alex Rayón, Co-founder and CEO of Brainandcode.tech and Marta Bilbao, Director of Innovation, Data and Digital Transformation of the Community of Madrid.

In this context, Joseba Laka, Digital Director of Tecnalia and round table moderator, began a debate focused on collaboration between the administration and the private sector in connection with education and the legal framework under which neurocomputing is advancing.

Marta Bilbao took the floor and stressed that “administrations work to improve the lives of citizens. The idea is that, thanks to Artificial Intelligence, we can customise service to each citizen.”

Subsequently, Erdozain explained the impact of the regulations on the use of Artificial Intelligence in the healthcare field. “It is true that the impact is enormous, but we have to take into account that in each process there is a regulation, and we have to make sure that they complement each other.” Speaking of regulations in research, he commented that “sometimes they are seen as an enemy, but this should not be the case. The regulations set red lines that are reasonably flexible.”

The collection of patient data for research purposes can sometimes be reused for a process other than the one the patient was suffering from. For this reason, the Of counsel of PONS IP stressed that it is important for this recycling of data to be “consensual, informed and free on the part of the affected party.” To close the debate, Alex Rayón explained that the collaboration between universities and companies is not so much to “educate, but rather to keep processes, which are currently undergoing continuous evolution, up to date. Therefore, the importance of implementing these technologies is not in the first impact on productivity, but afterwards. You end up becoming a surveillance system in the face of new developments.”

LEGAL NOTICE PRESS ARTICLES REGULATED BY CEDRO:
Some of the journalistic articles included in this website are protected by Copyright. If you wish to carry out the reproduction, distribution, public communication or transformation, in any medium and in any way, of any article with the employees of your company or with external personnel, contact CEDRO to obtain your own authorization (licenses@cedro.org /cedrocat@cedro.org)

If you liked this content, share it:

Listen to our podcast

“Invention Privileges”

episodio 2
Las marcas en la nueva economía digital
El segundo episodio de nuestro podcast “Privilegios de Invención” está dedicado a uno de los derechos de propiedad industrial más...
episodio 1
Patentes Biotecnológicas
El primer episodio estará dedicado a uno de los grandes campos de la innovación a nivel mundial, uno de los...

NEWSLETTER

All the IP News

in your e-mail

Find out all the latest information on IP to boost the development of your organisation.

Subscribe to our bimonthly newsletter

In compliance with the provisions of the GDPR, the following is informed: Controller: PONS IP, S.A. (A-28750891). Purposes: send of electronic marketing communications related to the activities and services offered by PONS IP. Legitimation: Consent of the interested party [art. 6.1.a) GDPR]. Rights: Access, rectify, delete, limit, or oppose the treatment, request portability and revoke the consent given by sending an email to rgpd@ponsip.com, including as a reference "EXERCISE OF RIGHTS". More information.

International Awards

and Recognitions

International Awards and Recognitions